EXOZYMES INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
EXOZYMES INC. (EXOZ) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $122.65 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $122.65K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $142.44K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $163.53K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $185.88K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $122.65K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $142.44K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $163.53K 10-K · filed 2026-03-30 |
| 2025-09-30 | $185.88K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $209.45K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $234.21K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $260.12K 10-K · filed 2025-03-31 |
| 2024-09-30 | $287.17K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |